Source: Annual Congress 2006 - Epidemiology, clinical features, malignant pleural diseases, treatment
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Welker, M. Müller, O. Holz, R. A. Jörres, H. Magnussen (Großhansdorf, Itzehoe, Munich, Germany). Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions. Eur Respir J 2006; 28: Suppl. 50, 4489

Member's Comments

No comment yet.

Related content which might interest you: Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Diagnostic efficiency of pleural fluid lipid-bound sialic acid level in malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004 Ideal volume sampling in the diagnosis of malignant pleural effusions Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Zoledronic acid limits experimental malignant pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 435s Year: 2007 Thoracoscopy and malignant pleural mesothelioma Source: ERS Course 2015 Year: 2015 Diagnostic problems in benign and malignant pleural effusions Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results Source: Eur Respir J 2005; 26: 989-992 Year: 2005 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017